Tacalcitol
Chemical compound
Tacalcitol (1,24-dihydroxyvitamin D3) is a synthetic vitamin D3 analog. Tacalcitol is marketed under several names, including Curatoderm and Bonalfa.
![]() | |
Clinical data | |
---|---|
Other names | (1α,24R)-1,24-Dihydroxyvitamin D3 |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Topical |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
ChemSpider | |
UNII | |
ChEBI | |
ChEMBL | |
Chemical and physical data | |
Formula | C27H44O3 |
Molar mass | 416.646 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
It is on the World Health Organization's List of Essential Medicines.
Mechanism
Tacalcitol reduces excessive cell turnover in the epidermis by interacting with vitamin D receptors on keratinocytes.
Uses
It is usually prescribed by a general practitioner or dermatologist for the treatment of psoriasis, chronic chapped lips and other severe dry skin conditions because of its ability to reduce excessive skin cell turnover.[1] It is available as an ointment or lotion.
It has also been used for vitiligo and Hailey-Hailey disease.
この記事は、クリエイティブ・コモンズ・表示・継承ライセンス3.0のもとで公表されたウィキペディアの項目Tacalcitol(11 February 2024編集記事参照)を素材として二次利用しています。 Item:Q22024 |
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs namedpmid9257082